IP Library Granted Patent US 9,072,792
Granted Patent B2
US 9,072,792 · App. 13/155,168 · Granted Jul 7, 2015

Peptides whose uptake by cells is controllable

Inventors: Tao Jiang (Rancho Santa Fe, CA); Emilia S. Olson (La Jolla, CA); Michael Whitney (San Diego, CA); Roger Tsien (La Jolla, CA)
Assignee: The Regents of the University of California
A61K47/48246A61K41/0095A61K47/48315A61K47/48338A61K49/0032A61K49/0043A61K49/0056A61K49/085A61K49/14A61K49/146A61K51/088C07K14/4728
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,072,792
App. No.
13/155,168
Granted
Jul 7, 2015
Kind
B2
Abstract

A generic structure for the peptides of the present invention includes A-X-B-C, where C is a cargo moiety, the B portion includes basic amino acids, X is a cleavable linker sequence, and the A portion includes acidic amino acids. The intact structure is not significantly taken up by cells; however, upon extracellular cleavage of X, the B-C portion is taken up, delivering the cargo to targeted cells. Cargo may be, for example, a contrast agent for diagnostic imaging, a chemotherapeutic drug, or a radiation-sensitizer for therapy. X may be cleaved extracellularly or intracellularly. The molecules of the present invention may be linear, cyclic, branched, or have a mixed structure.

Claims (12)

1. A method for labeling a cell, comprising contacting the cell with a molecule comprising the structure

A-X-B-C  (Formula I),

wherein

C is a fluorescent moiety,

B is a peptide sequence comprising a series of 8 D-arginine residues,

A is a peptide sequence comprising a series of 5 glutamate residues, and

X is a cleavable linker.

2. The method of claim 1 , wherein X is a pH-sensitive linker.

3. The method of claim 1 , wherein X is cleaved in the extracellular space.

4. The method of claim 1 , wherein X is cleaved by a protease, a matrix metalloproteinase, or a combination thereof.

5. The method of claim 1 , further comprising a fluorescent quenching moiety attached to A.

6. The method of claim 1 , wherein the fluorescent moiety is a fluorescent cyanine.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 7, 2012
From: UNIVERSITY OF CALIFORNIA AT SAN DIEGO
To: US ARMY, SECRETARY OF THE ARMY
Reel/Frame 028739/0100 →
CONFIRMATORY LICENSE Recorded Aug 18, 2011
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026769/0250 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 24, 2011
From: JIANG, TAO; OLSON, EMILIA S.; WHITNEY, MICHAEL; TSIEN, ROGER
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 026492/0119 →
Continuity (3)
Continuation 11133804 · May 19, 2005
Continuation In Part 10699562 · Oct 31, 2003
Related Publication 20120014873A1 · Jan 19, 2012